I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 23% ± 6% | |
| CD8-positive, alpha-beta T cell | 6 studies | 16% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 20% ± 4% | |
| capillary endothelial cell | 5 studies | 30% ± 8% | |
| natural killer cell | 5 studies | 19% ± 2% | |
| endothelial cell of artery | 5 studies | 35% ± 13% | |
| astrocyte | 5 studies | 30% ± 12% | |
| epithelial cell | 4 studies | 26% ± 8% | |
| regulatory T cell | 4 studies | 18% ± 3% | |
| macrophage | 4 studies | 20% ± 2% | |
| classical monocyte | 3 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 3% | |
| basal cell | 3 studies | 19% ± 4% |
